$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Redispersible nanoparticulate film matrices with protective overcoats 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/16
  • A61K-009/50
출원번호 US-0387651 (1995-02-13)
발명자 / 주소
  • Desieno Mark A. (Gilbertsville PA) Stetsko Gregg (Harleysville PA)
출원인 / 주소
  • Nano Systems L.L.C. (Collegeville PA 02)
인용정보 피인용 횟수 : 133  인용 특허 : 0

초록

A pharmaceutical film matrix comprising nanoparticles of a low solubility drug associated with a steric stabilizer and a film dispersing agent is coated on the surface of carrier particles and overcoated with a protective layer. Pharmaceutical compositions comprising the film matrix-coated carrier e

대표청구항

A solid pharmaceutical composition comprising a capsule shell containing carrier particles, each particle having on its surface a film comprising nanoparticles of a low solubility drug associated with a steric stabilizer and a film dispersing agent, wherein dissolution of the solid pharmaceutical co

이 특허를 인용한 특허 (133)

  1. Terry, Richard, Antimicrobial compositions containing colloids of oligodynamic metals.
  2. François, Marc Karel Jozef; Dries, Willy Maria Albert Carlo; Basstanie, Esther Dina Guido, Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters.
  3. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
  4. Patel, Mahesh V.; Chidambaram, Nachiappan; Nachaegari, Satish Kumar; Venkateshwaran, Srinivasan; Frank, Joel, Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters.
  5. Tiwari, Deepak; Owoo, George; Nayak, Rekha; Burhop, Kenneth E., Colored esmolol concentrate.
  6. Cooper, Eugene R.; Ruddy, Stephen B., Compositions having a combination of immediate release and controlled release characteristics.
  7. Kipp,James E.; Doty,Mark J.; Rebbeck,Christine L.; Brynjelsen,Sean; Konkel,Jamie Teresa, Compositions of and method for preparing stable particles in a frozen aqueous matrix.
  8. Knoll, Robert; Mueller, Chad, Containers having improved barrier and mechanical properties.
  9. Swanson, Jon; Jain, Rajeev A.; Hontz, Robert; Devane, John G.; Cumming, Kenneth Iain; Clancy, Maurice Joseph Anthony; Codd, Janet Elizabeth; Liversidge, Gary, Controlled-release nanoparticulate compositions.
  10. Kararli,Tugrul T.; Kontny,Mark J.; Desai,Subhash; Hageman,Michael J.; Haskell,Royal J., Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect.
  11. Domb,Abraham J., Dispersible concentrate for the delivery of cyclosprin.
  12. Graiver Daniel ; Pernisz Udo C., Encapsulated silica nanoparticles.
  13. Myers, Garry L.; Fuisz, Richard C., Film compositions for delivery of actives.
  14. Kodas, Toivo T.; Hampden-Smith, Mark J.; Kunze, Klaus; Dericotte, David E.; Vanheusden, Karel; Stump, Aaron, Gas dispersion manufacture of nanoparticulates, and nanoparticulate-containing products and processing thereof.
  15. McGurk, Simon L.; Czekai, David A., Gel stabilized nanoparticulate active agent compositions.
  16. Bosch, H. William; Ryde, Niels P.; Jain, Rajeev A.; Swanson, Jon; Hontz, Robert; Devane, John G.; Cumming, Kenneth Ian; Clancy, Maurice Joseph Anthony; Codd, Janet Elizabeth; Liversidge, Gary G., Glipizide compositions.
  17. Oraevsky,Alexander A.; Henrichs,Paul M., High contrast optoacoustic imaging using nanoparticles.
  18. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  19. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  20. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  21. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  22. Giliyar, Chandrashekar; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  23. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  24. Giliyar, Chandrashekar; Chickmath, Basawaraj; Nachiappan, Chidambaram; Patel, Mahesh V.; Venkateshwaran, Srinivansan, High-strength testosterone undecanoate compositions.
  25. Giliyar, Chandrashekar; Venkateshwaran, Srinivasan; Chickmath, Basawaraj; Chidambaram, Nachiappan; Patel, Mahesh V, High-strength testosterone undecanoate compositions.
  26. Trollsas, O. Mikael; Ngo, Michael H.; Sherman, David J.; Hossainy, Syed F. A., Implantable device having a slow dissolving polymer.
  27. Trollsas, O. Mikael; Ngo, Michael H.; Sherman, David J.; Hossainy, Syed F. A., Implantable device with a triblock polymer coating.
  28. Cooper, Eugene R.; Bullock, John A.; Chippari, John R.; Schaefer, John L.; Patel, Rakesh A.; Jain, Rajeev; Strasters, Joost; Ryde, Niels P.; Ruddy, Stephen B., In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions.
  29. Cooper, Eugene R.; Bullock, John A.; Chippari, John R.; Schaefer, John L.; Patel, Rakesh A.; Jain, Rajeev; Strasters, Joost; Ryde, Niels P.; Ruddy, Stephen B., In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions.
  30. Haskell, Royal J., Laboratory scale milling process.
  31. Shaw, Kenneth; Zhang, Mingbao, Liquid ganaxolone formulations and methods for the making and use thereof.
  32. Shaw, Kenneth; Zhang, Mingbao, Liquid ganaxolone formulations and methods for the making and use thereof.
  33. Kipp, James E.; Wong, Joseph Chung Tak; Doty, Mark J.; Werling, Jane; Rebbeck, Christine L.; Brynjelsen, Sean, Method for preparing submicron particle suspensions.
  34. Chaubal, Mahesh; Werling, Jane; Rabinow, Barrett, Method for preparing submicron particles of antineoplastic agents.
  35. Werling, Jane; Kipp, James E.; Sriram, Rajaram; Doty, Mark J., Method for preparing submicron suspensions with polymorph control.
  36. Davalian, Dariush, Method for the manufacture of stable, nano-sized particles.
  37. Davalian, Dariush, Method for the manufacture of stable, nano-sized particles.
  38. Rabinow, Barrett; White, Randy; Sun, Chong-Son; Wong, Joseph Chung Take; Kipp, James E.; Doty, Mark; Rebbeck, Christine L.; Papadopoulos, Pavlos, Method for treating infectious organisms normally considered to be resistant to an antimicrobial drug.
  39. Hassan, EmadEldin M., Method of making nanoparticles of substantially water insoluble materials.
  40. Wertz, Christian F.; Ryde, Niels P., Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer.
  41. Grabstein, Kenneth H.; Wang, Aijun; Nairn, Natalie Winblade; Graddis, Thomas James, Methods of modifying polypeptides comprising non-natural amino acids.
  42. Ryde,Tuula; Gustow,Evan E.; Ruddy,Stephen B.; Jain,Rajeev; Patel,Rakesh; Wilkins,Michael John, Methods of treatment using nanoparticulate fenofibrate compositions.
  43. Terry, Richard N., Microbe-resistant medical device, microbe-resistant polymeric coating and methods for producing same.
  44. Kipp, James E.; Wong, Joseph Chung Tak; Doty, Mark J.; Rebbeck, Christine L., Microprecipitation method for preparing submicron suspensions.
  45. Kipp, James E.; Wong, Joseph Chung Tak; Doty, Mark J.; Rebbeck, Christine L., Microprecipitation method for preparing submicron suspensions.
  46. Kipp,James E.; Wong,Joseph Chung Tak; Doty,Mark J.; Rebbeck,Christine L., Microprecipitation method for preparing submicron suspensions.
  47. Sulaiman, Brian; Souleyman, Abdul Karem, Milling system.
  48. Grabstein, Kenneth H.; Wang, Aijun; Nairn, Natalie Winblade; Graddis, Thomas James; McCraith, Stephen; Datta, Deepshikha, Modified human interferon-beta polypeptides.
  49. Grabstein, Kenneth H.; Wang, Andrea; Nairn, Natalie Winblade; McCraith, Stephen; Datta, Deepshikha, Modified human interferon-β polypeptides.
  50. Burger,Jack; Campanile,Fabio; Corda,Guiseppe; Doorn,Louis; Orsel,Roel; Witteveen,Frans, Moisture and oxygen stable composition and a process for obtaining said composition.
  51. Tiwari, Deepak; Owoo, George; Nayak, Rekha; Burhop, Kenneth E., Multi-dose concentrate esmolol with benzyl alcohol.
  52. Bloom, Corey Jay; Crew, Marshall David; Smithey, Daniel Tod; Miller, Warren Kenyon; Morgen, Michael Mark, Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer.
  53. Miller, Warren Kenyon; Morgen, Michael Mark; Smithey, Daniel Tod, Nanoparticles comprising a drug, ethylcellulose, and a bile salt.
  54. Bloom, Corey Jay; Crew, Marshall David; Miller, Warren Kenyon; Morgen, Michael Mark; Smithey, Daniel Tod, Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer.
  55. Bloom, Corey J.; Crew, Marshall David; Miller, Warren Kenyon, Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer.
  56. Miller, Warren Kenyon, Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate.
  57. Devane, John G; Stark, Paul; Fanning, Niall M. N.; Rekhi, Gurvinder Singh; Jenkins, Scott A.; Liversidge, Gary, Nanoparticulate and controlled release compositions comprising cefditoren.
  58. Jenkins, Scott A.; Liversidge, Gary, Nanoparticulate and controlled release compositions comprising cyclosporine.
  59. Liversidge, Gary G.; Jenkins, Scott, Nanoparticulate bisphosphonate compositions.
  60. Liversidge, Gary; Jenkins, Scott, Nanoparticulate carverdilol formulations.
  61. Neville, Deborah; Jenkins, Scott; Manser, David, Nanoparticulate cinacalcet compositions.
  62. Cunningham, James; Liversidge, Elaine Merisko, Nanoparticulate compositions having a peptide as a surface stabilizer.
  63. Wertz, Christian F.; Ryde, Niels P., Nanoparticulate compositions having lysozyme as a surface stabilizer.
  64. Wertz,Christian F.; Ryde,Niels P., Nanoparticulate compositions having lysozyme as a surface stabilizer.
  65. Bosch, H. William; Cary, Greta G.; Hovey, Douglas C.; Jain, Rajeev A.; Kline, Laura J.; Merisko-Liversidge, Elaine; Ostrander, Kevin D.; Ryde, Niels P.; Ruddy, Stephen B., Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors.
  66. Liversidge, Gary; Jenkins, Scott; Bosch, H. William; Wertz, Christian F., Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof.
  67. Ryde,Tuula; Gustow,Evan E.; Ruddy,Stephen B.; Jain,Rajeev; Patel,Rakesh; Wilkins,Michael John, Nanoparticulate fibrate formulations.
  68. Hovey, Douglas; Pruitt, John; Ryde, Tuula, Nanoparticulate megestrol formulations.
  69. Hovey, Douglas; Pruitt, John; Ryde, Tuula, Nanoparticulate megestrol formulations.
  70. Hovey, Douglas; Pruitt, John; Ryde, Tuula, Nanoparticulate megestrol formulations.
  71. Hovey, Douglas; Pruitt, John; Ryde, Tuula, Nanoparticulate megestrol formulations.
  72. Hovey, Douglas; Pruitt, John; Ryde, Tuula, Nanoparticulate megestrol formulations.
  73. Hovey,Douglas; Pruitt,John; Ryde,Tuula, Nanoparticulate megestrol formulations.
  74. Cooper, Eugene R.; Ryde, Tuula; Pruitt, John; Kline, Laura, Nanoparticulate meloxicam formulations.
  75. Cooper, Eugene R.; Kline, Laura; Liversidge, Gary G.; Ryde, Niels P., Nanoparticulate polycosanol formulations and novel polycosanol combinations.
  76. Liversidge, Gary G.; Jenkins, Scott, Nanoparticulate quinazoline derivative formulations.
  77. Gustow,Evan; Ryde,Tuula; Cooper,Eugene R., Nanoparticulate topiramate formulations.
  78. Cayton,Roger H.; Brotzman, Jr.,Richard W., Nanostructured compositions.
  79. Cho Moo J. ; Levy Ralph E. ; Pouletty Philippe J., Oral cyclosphorin formulations.
  80. Bosch, H. William; Liversidge, Elaine; Shelukar, Suhas D.; Thompson, Karen C., Pharmaceutical composition of a tachykinin receptor antagonist.
  81. Miller, Warren Kenyon; Smithey, Daniel; Frankamp, Benjamin Lee; Tadday, Ralph, Pharmaceutical compositions comprising nanoparticles and a resuspending material.
  82. Babcock, Walter C.; Caldwell, William B.; Crew, Marshall D.; Friesen, Dwayne T.; Shanker, Ravi M.; Smithey, Daniel T., Pharmaceutical compositions of semi-ordered drugs and polymers.
  83. Babcock, Walter C.; Caldwell, William B.; Crew, Marshall D.; Friesen, Dwayne T.; Shanker, Ravi M.; Smithey, Daniel T., Pharmaceutical compositions of semi-ordered drugs and polymers.
  84. Curatolo, William J.; Shanker, Ravi M.; Babcock, Walter C.; Friesen, Dwayne T.; Nightingale, James A. S.; Lorenz, Douglas A., Pharmaceutical compositions providing enhanced drug concentrations.
  85. Curatolo, William J.; Shanker, Ravi M.; Babcock, Walter C.; Friesen, Dwayne T.; Nightingale, James A. S.; Lorenz, Douglas A., Pharmaceutical compositions providing enhanced drug concentrations.
  86. Curatolo, William J.; Shanker, Ravi M.; Babcock, Walter C.; Friesen, Dwayne T.; Nightingale, James A. S.; Lorenz, Douglas A., Pharmaceutical compositions providing enhanced drug concentrations.
  87. Curatolo, William J.; Shanker, Ravi M.; Babcock, Walter C.; Friesen, Dwayne T.; Nightingale, James A. S.; Lorenz, Douglas A., Pharmaceutical compositions providing enhanced drug concentrations.
  88. Curatolo, William J.; Shanker, Ravi M.; Babcock, Walter C.; Friesen, Dwayne T.; Nightingale, James A. S.; Lorenz, Douglas A., Pharmaceutical compositions providing enhanced drug concentrations.
  89. Ferro,Leonard J.; Miyake,Patricia S., Polymorphic crystalline forms of celecoxib.
  90. Werling,Jane; Doty,Mark J.; Rebbeck,Christine L.; Wong,Joseph Chung Tak; Kipp,James E., Polymorphic form of itraconazole.
  91. Brynjelsen, Sean; Doty, Mark; Kipp, James E.; Jayswal, Nailesh; Narayanan, Krishnaswamy, Preparation of submicron sized nanoparticles via dispersion lyophilization.
  92. Brynjelsen, Sean; Doty, Mark; Kipp, James E.; Jayswal, Nailesh; Narayanan, Krishnaswamy, Preparation of submicron sized nanoparticles via dispersion lyophilization.
  93. Domb, Abraham J.; Avramoff, Avi; Pevzner, Victor, Pro-nanodispersion for the delivery of cyclosporin.
  94. Yang, Robert K.; Fuiz, Richard C.; Myers, Garry L.; Fuiz, Joseph M., Process for making a film having a substantially uniform distribution of components.
  95. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Process for manufacturing a resulting multi-layer pharmaceutical film.
  96. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Process for manufacturing a resulting multi-layer pharmaceutical film.
  97. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Process for manufacturing a resulting pharmaceutical film.
  98. Kerkhof,Nicholas J., Process for producing nanometer particles by fluid bed spray-drying.
  99. Kerkhof, Nicholas J., Process for producing nanoparticles by spray drying.
  100. Ryde, Niels P.; Snyder, Peter; Liu, Wei; Slifer, David M., Reduction of flake-like aggregation in nanoparticulate active agent compositions.
  101. Ryde, Niels P.; Snyder, Peter; Liu, Wei; Slifer, David M., Reduction of flake-like aggregation in nanoparticulate active agent compositions.
  102. Ryde, Niels P.; Snyder, Peter; Liu, Wei; Slifer, David M., Reduction of flake-like aggregation in nanoparticulate active agent compositions.
  103. Ryde, Niels P.; Snyder, Peter; Liu, Wei; Slifer, David M., Reduction of flake-like aggregation in nanoparticulate active agent compositions.
  104. Patel Mahesh V. ; Chen Feng-Jing, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
  105. Patel, Mahesh V.; Chen, Feng-Jing, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
  106. Patel, Mahesh V.; Chen, Feng-Jing, Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions.
  107. Shaw, Kenneth; Zhang, Mingbao, Solid ganaxolone formulations and methods for the making and use thereof.
  108. Shaw, Kenneth; Zhang, Mingbao, Solid ganaxolone formulations and methods for the making and use thereof.
  109. Allen, Kimberley C.; Clark, Jerry D.; Fraher, Thomas P.; Hanko, Jason A.; Kolbert, Kimberly L.; Little, Clay R.; Mao, Michael K.; Miyake, Patricia S.; Moe, Jodi L.; Mudipalli, Partha S.; Schilke, Tob, Solid-state forms of N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl) pyrazole.
  110. Chad Mueller ; Thomas Lee ; Alain Jupin FR, Squeezable containers for flowable products having improved barrier and mechanical properties.
  111. Shaw, Kenneth; Zhang, Mingbao, Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof.
  112. Shaw, Kenneth; Zhang, Mingbao, Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof.
  113. Bosch, H. William; Keller, Janine, Sterilization of dispersions of nanoparticulate active agents with gamma radiation.
  114. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
  115. Giliyar, Chandrashekar; Chidambaram, Nachiappan; Patel, Mahesh V.; Venkateshwaran, Srinivasan, Steroidal compositions.
  116. Chaubal, Mahesh; Doty, Mark J.; Konkel, Jamie T.; Rabinow, Barrett E., Surfactant systems for delivery of organic compounds.
  117. Reed, Robert G.; Czekai, David, System and method for milling materials.
  118. Chad Mueller ; Roger Kaas ; Bertrand Fillon FR; Sandrine Tournier FR; Jean-Jacques Lerda FR, Thermoplastic film structures having improved barrier and mechanical properties.
  119. Mueller, Chad; Kaas, Roger; Fillon, Bertrand; Tournier, Sandrine; Lerda, Jean-Jacques, Thermoplastic film structures having improved barrier and mechanical properties.
  120. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom.
  121. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  122. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  123. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  124. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  125. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  126. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  127. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  128. Anderson, David; Cameransi, Jr., Benjamin G.; Conklin, Vincent M., Treatment using dantrolene.
  129. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Uniform films for rapid dissolve dosage form incorporating taste-masking compositions.
  130. Yang, Robert K.; Fuisz, Richard C.; Myers, Garry L.; Fuisz, Joseph M., Uniform films for rapid dissolve dosage form incorporating taste-masking compositions.
  131. Myers, Garry L.; Sanghvi, Pradeep; Verrall, Andrew Philip; Francis, Vimala; Brooks, Laura, Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions.
  132. Myers, Garry L.; Sanghvi, Pradeep; Verrall, Andrew Philip; Francis, Vimala; Moss, Laura, Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions.
  133. Karim, Aziz; Brugger, Andrew M.; Gao, Ping; Hassan, Fred; Forbes, James C., Use of a celecoxib composition for fast pain relief.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로